BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 15584433)

  • 1. [Vaccination strategies for anthrax prevention].
    Beyer W
    Berl Munch Tierarztl Wochenschr; 2004; 117(11-12):508-24. PubMed ID: 15584433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.
    Cote CK; Rossi CA; Kang AS; Morrow PR; Lee JS; Welkos SL
    Microb Pathog; 2005; 38(5-6):209-25. PubMed ID: 15925272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the development of next-generation anthrax vaccines.
    Friedlander AM; Little SF
    Vaccine; 2009 Nov; 27 Suppl 4():D28-32. PubMed ID: 19837282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of recombinant anthrax vaccine against Bacillus anthracis aerosol spore challenge: preclinical evaluation in rabbits and Rhesus monkeys.
    Chawla A; Midha S; Bhatnagar R
    Biotechnol J; 2009 Mar; 4(3):391-9. PubMed ID: 19296443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective activity and immunogenicity of two recombinant anthrax vaccines for veterinary use.
    Fasanella A; Tonello F; Garofolo G; Muraro L; Carattoli A; Adone R; Montecucco C
    Vaccine; 2008 Oct; 26(45):5684-8. PubMed ID: 18775462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA vaccination against anthrax in mice-combination of anti-spore and anti-toxin components.
    Hahn UK; Boehm R; Beyer W
    Vaccine; 2006 May; 24(21):4569-71. PubMed ID: 16157424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
    Mikshis NI; Kudriavtseva OM; Bolothikova MF; Shulepov DV; Novikova LV; Popov IuA; Shchukovskaia TN; Drozdov IG; Kutyrev VV
    Mol Gen Mikrobiol Virusol; 2007; (3):15-21. PubMed ID: 17886469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BclA and toxin antigens augment each other to protect NMRI mice from lethal Bacillus anthracis challenge.
    Köhler SM; Baillie LW; Beyer W
    Vaccine; 2015 Jun; 33(24):2771-7. PubMed ID: 25917676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress on the vaccine for anthrax].
    Zhan DW; Wang P; Wang LC; Zhang ZS
    Wei Sheng Wu Xue Bao; 2005 Feb; 45(1):149-52. PubMed ID: 15847185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.
    Tournier JN; Ulrich RG; Quesnel-Hellmann A; Mohamadzadeh M; Stiles BG
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):219-36. PubMed ID: 19254170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis for improved anthrax vaccines.
    Brey RN
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1266-92. PubMed ID: 15935874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
    Mendelson I; Gat O; Aloni-Grinstein R; Altboum Z; Inbar I; Kronman C; Bar-Haim E; Cohen S; Velan B; Shafferman A
    Vaccine; 2005 Dec; 23(48-49):5688-97. PubMed ID: 16039760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.
    Little SF; Knudson GB
    Infect Immun; 1986 May; 52(2):509-12. PubMed ID: 3084385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccines against anthrax in animals, from Louis Pasteur to our day].
    Shlyakhov E; Blancou J; Rubinstein E
    Rev Sci Tech; 1996 Sep; 15(3):853-62. PubMed ID: 9376647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary trials of oral immunization of wild animals against anthrax].
    Rengel J; Böhnel H
    Berl Munch Tierarztl Wochenschr; 1994 May; 107(5):145-9. PubMed ID: 8067984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Past, imminent and future human medical countermeasures for anthrax.
    Baillie LW
    J Appl Microbiol; 2006 Sep; 101(3):594-606. PubMed ID: 16907809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
    Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation, control and application of anthrax vaccine in USSR].
    Romanov GI
    Arch Exp Veterinarmed; 1980; 34(1):119-22. PubMed ID: 6774689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization.
    Herrmann JE; Wang S; Zhang C; Panchal RG; Bavari S; Lyons CR; Lovchik JA; Golding B; Shiloach J; Lu S
    Vaccine; 2006 Jul; 24(31-32):5872-80. PubMed ID: 16790303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.